Titan Pharmaceuticals
TTNP
#10362
Rank
โ‚น0.57 B
Marketcap
โ‚น428.69
Share price
-3.76%
Change (1 day)
24.72%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น408.23. In 2023 the company made an earnings per share (EPS) of -โ‚น689.06 an increase over its 2022 EPS that were of -โ‚น1,413.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น689.06-51.22%
2022-โ‚น1,413-15.61%
2021-โ‚น1,674-81.37%
2020-โ‚น8,983-77.52%
2019-โ‚น39,968-56.32%
2018-โ‚น91,504-59.51%
2017-โ‚น2,26,015-371.81%
2016โ‚น83,151-144.35%
2015-โ‚น1,87,471300%
2014-โ‚น46,868-121.54%
2013โ‚น2,17,601-151.38%
2012-โ‚น4,23,485-11.54%
2011-โ‚น4,78,722188.89%
2010-โ‚น1,65,711-10%
2009-โ‚น1,84,124
2007-โ‚น7,54,908-2.38%
2006-โ‚น7,73,320-39.13%
2005-โ‚น12,70,454-16.87%
2004-โ‚น15,28,228-22.43%
2003-โ‚น19,70,1254.9%
2002-โ‚น18,78,06361.9%
2001-โ‚น11,59,980-13.7%
2000-โ‚น13,44,10465.01%
1999-โ‚น8,14,572-35.87%
1998-โ‚น12,70,238-1824.71%
1997โ‚น73,650-102.4%
1996-โ‚น30,74,868

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,036-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น684.41-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น132.05-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.79-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.25-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น314.31-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA